DNA ligation catalyzed by human topoisomerase IIα

Biochemistry

Volumn 43, Issue 42, 2004, Pages 13416-13423

  Bromberg, Kenneth D ^a,d   Vélez Cruz, Renier ^a   Burgin, Alex B ^c   Osheroff, Neil ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c DECODE GENETICS   (Iceland)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CATALYSIS; CHEMICAL BONDS; ENZYMES; GENES; PHENOLS; REACTION KINETICS;

DNA LIGATION; LIGATION ASSAYS; NUCLEIC ACID; TOPOISOMERASE;

DNA;

4 NITROPHENOL; DNA TOPOISOMERASE (ATP HYDROLYSING); TYROSINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; COVALENT BOND; DNA BINDING; DNA CLEAVAGE; DNA DETERMINATION; DNA STRAND; ENZYME BINDING; PRIORITY JOURNAL;

EID: 6344226531     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049420h     Document Type: Article

References (66)

1. Pages, V., and Fuchs, R. P. (2002) How DNA lesions are turned into mutations within cells, Oncogene 21, 8957-8966.
2. Showalter, A. K., and Tsai, M. D. (2002) A reexamination of the nucleotide incorporation fidelity of DNA polymerases, Biochemistry 41, 10571-10576.
3. Kunkel, T. A., and Bebenek, K. (2000) DNA replication fidelity, Annu. Rev. Biochem. 69, 497-529.
4. Pfeiffer, P., Goedecke, W., and Obe, G. (2000) Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations, Mutagenesis 15, 289-302.
5. Flores-Rozas, H., and Kolodner, R. D. (2000) Links between replication, recombination and genome instability in eukaryotes, Trends Biochem. Sci. 25, 196-200.
6. Kaufmann, S. H. (1998) Cell death induced by topoisomerase-targeted drugs: more questions than answers, Biochim. Biophys. Acta 1400, 195-211.
7. Baguley, B. C., and Ferguson, L. R. (1998) Mutagenic properties of topoisomerase-targeted drugs, Biochim. Biophys. Acta 1400, 213-222.
8. Fortune, J. M., and Osheroff, N. (2000) Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice, Prog. Nucleic Acid Res. Mol. Biol. 64, 221-253.
9. Li, T. K., and Liu, L. F. (2001) Tumor cell death induced by topoisomerase-targeting drugs, Annu. Rev. Pharmacol. Toxicol. 41, 53-77.
10. Wilstermann, A. M., and Osheroff, N. (2002) Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes, Curr. Topics Med. Chem. 3, 1349-1364.
11. Bromberg, K. D., and Osheroff, N. (2003) in DNA Topoisomerases in Cancer Therapy: Present and Future (Andoh, T., Ed.) pp 53-78, Kluwer Academic/Plenum Publishers, New York.
12. Nitiss, J. L. (1998) Investigating the biological functions of DNA topoisomerases in eukaryotic cells, Biochim. Biophys. Acta 1400, 63-81.
13. Sabourin, M., and Osheroff, N. (2002) in Encyclopedia of Molecular Medicine (Creighton, T. E., Ed.) pp 3192-7319, Wiley, New York.
14. Wang, J. C. (2002) Cellular roles of DNA topoisomerases: a molecular perspective, Nat. Rev. Mol. Cell. Biol. 3, 430-40.
15. Berger, J. M. (1998) Structure of DNA topoisomerases, Biochim. Biophys. Acta 1400, 3-18.
16. Wang, J. C. (1998) Moving one DNA double helix through another by a type II DNA topoisomerase: the story of a simple molecular machine, Q. Rev. Biophys. 31, 107-144.
17. Champoux, J. J. (2001) DNA topoisomerases: structure, function, and mechanism, Annu. Rev. Biochem. 70, 369-413.
18. Liu, L. F., Rowe, T. C., Yang, L., Tewey, K. M., and Chen, G. L. (1983) Cleavage of DNA by mammalian DNA topoisomerase II, J. Biol. Chem. 258, 15365-15370.
19. Sander, M., and Hsieh, T. (1983) Double strand DNA cleavage by type II DNA topoisomerase from Drosophila melanogaster, J. Biol. Chem. 258, 8421-8428.
20. Zechiedrich, E. L., Christiansen, K., Andersen, A. H., Westergaard, O., and Osheroff, N. (1989) Double-stranded DNA cleavage/ religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate, Biochemistry 28, 6229-6236.
21. Felix, C. A. (1998) Secondary leukemias induced by topoisomerase-targeted drugs, Biochim. Biophys. Acta 1400, 233-255.
22. Rowley, J. D. (1998) The critical role of chromosome translocations in human leukemias, Annu. Rev. Genet. 32, 495-519.
23. Hande, K. R. (1998) Clinical applications of anticancer drugs targeted to topoisomerase II, Biochim. Biophys. Acta 1400, 173-184.
24. Hande, K. R. (1998) Etoposide: four decades of development of a topoisomerase II inhibitor, Eur. J. Cancer 34, 1514-1521.
25. Pommier, Y., Fesen, M. R., and Goldwasser, F. (1996) in Cancer Chemotherapy and Biotherapy: Principles and Practice (Chabner, B. A., and Longo, D. L., Eds.) pp 435-461, Lippincott-Raven Publishers, Philadelphia, PA.
26. Pommier, Y. (1997) in Cancer Therapeutics: Experimental and Clinical Agents (Teicher, B. A., Ed.) pp 153-174, Humana Press, Totowa, NJ.
27. Walker, J. V., and Nitiss, J. L. (2002) DNA topoisomerase II as a target for cancer chemotherapy, Cancer Invest. 20, 570-589.
28. Ross, J. A., Potter, J. D., Reaman, G. H., Pendergrass, T. W., and Robison, L. L. (1996) Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group, Cancer Causes Control 7, 581-590.
29. Ross, J. A. (1998) Maternal diet and infant leukemia: a role for DNA topoisomerase II inhibitors?, Int. J. Cancer Suppl. 11, 26-28.
30. Felix, C. A., and Lange, B. J. (1999) Leukemia in infants, Oncologist 4, 225-240.
31. Felix, C. A. (2001) Leukemias related to treatment with DNA topoisomerase II inhibitors, Med. Pediatr. Oncol. 36, 525-535.
32. Andoh, T., and Ishida, R. (1998) Catalytic inhibitors of DNA topoisomerase II, Biochim. Biophys. Acta 1400, 155-171.
33. Osheroff, N., and Zechiedrich, E. L. (1987) Calcium-promoted DNA cleavage by eukaryotic topoisomerase II: trapping the covalent enzyme-DNA complex in an active form, Biochemistry 26, 4303-4309.
34. Osheroff, N. (1989) Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide, Biochemistry 28, 6157-6160.
35. Robinson, M. J., and Osheroff, N. (1991) Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II, Biochemistry 30, 1807-1813.
36. Andersen, A. H., Sørensen, B. S., Christiansen, K., Svejstrup, J. Q., Lund, K., and Westergaard, O. (1991) Studies of the topoisomerase II-mediated cleavage and religation reactions by use of a suicidal double-stranded DNA substrate, J. Biol. Chem. 266, 9203-9210.
37. Bromberg, K. D., Hendricks, C., Burgin, A. B., and Osheroff, N. (2002) Human topoisomerase IIα possesses an intrinsic nucleic acid specificity for DNA ligation. Use of 5′ covalently activated oligonucleotide substrates to study enzyme mechanism, J. Biol. Chem. 277, 31201-31206.
38. Bromberg, K. D., Burgin, A. B., and Osheroff, N. (2003) A two drug model for Etoposide action against human topoisomerase IIα, J. Biol. Chem. 278, 7406-7412.
39. Bromberg, K. D., Burgin, A. B., and Osheroff, N. (2003) Quinolone action against human topoisomerase IIα: Stimulation of enzyme-mediated double-stranded DNA cleavage, Biochemistry 42, 3393-3398.
40. Wasserman, R. A., Austin, C. A., Fisher, L. M., and Wang, J. C. (1993) Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast, Cancer Res. 53, 3591-3596.
41. Kingma, P. S., Greider, C. A., and Osheroff, N. (1997) Spontaneous DNA lesions poison human topoisomerase IIα and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints, Biochemistry 36, 5934-5939.
42. Wilstermann, A. M., and Osheroff, N. (2001) Positioning the 3′-DNA terminus for topoisomerase II-mediated religation, J. Biol. Chem. 276, 17727-17731.
43. Jones, D. H., and Howard, B. H. (1991) A rapid method for recombination and site-specific mutagenesis by placing homologous ends on DNA using polymerase chain reaction, BioTechniques 10, 62-66.
44. Bromberg, K. D., and Osheroff, N. (2001) DNA cleavage and religation by human topoisomerase IIα at high temperature, Biochemistry 40, 8410-8418.
45. Woodfield, G., Cheng, C., Shuman, S., and Burgin, A. B. (2000) Vaccinia topoisomerase and Cre recombinase catalyze direct ligation of activated DNA substrates containing a 3′-p-nitrophenyl phosphate ester, Nucleic Acids Res. 28, 3323-3331.
46. Drake, F. H., Zimmerman, J. P., McCabe, F. L., Bartus, H. F., Per, S. R., Sullivan, D. M., Ross, W. E., Mattern, M. R., Johnson, R. K., and Crooke, S. T. (1987) Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme, J. Biol. Chem. 262, 16739-16747.
47. Drake, F. H., Hofmann, G. A., Bartus, H. F., Mattern, M. R., Crooke, S. T., and Mirabelli, C. K. (1989) Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II, Biochemistry 28, 8154-8160.
48. Austin, C. A., and Marsh, K. L. (1998) Eukaryotic DNA topoisomerase IIβ, BioEssays 20, 215-226.
49. Heck, M. M., Hittelman, W. N., and Earnshaw, W. C. (1988) Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle, Proc. Natl. Acad. Sci. U.S.A. 85, 1086-1090.
50. Woessner, R. D., Mattern, M. R., Mirabelli, C. K., Johnson, R. K., and Drake, F. H. (1991) Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells, Cell Growth Differ. 2, 209-214.
51. Isaacs, R. J., Davies, S. L., Sandri, M. I., Redwood, C., Wells, N. J., and Hickson, I. D. (1998) Physiological regulation of eukaryotic topoisomerase II, Biochim. Biophys. Acta 1400, 121-137.
52. Bauman, M. E., Holden, J. A., Brown, K. A., Harker, W. G., and Perkins, S. L. (1997) Differential immunohistochemical staining for DNA topoisomerase IIα and β in human tissues and for DNA topoisomerase 11β in non-Hodgkin's lymphomas, Mod. Pathol. 10, 168-175.
53. Yang, X., Li, W., Prescott, E. D., Burden, S. J., and Wang, J. C. (2000) DNA topoisomerase IIβ and neural development, Science 287, 131-134.
54. Lyu, Y. L., and Wang, J. C. (2003) Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIβ, Proc. Natl. Acad. Sci. U.S.A. 100, 7123-7128.
55. Strumberg, D., Nitiss, J. L., Dong, J., Kohn, K. W., and Pommier, Y. (1999) Molecular analysis of yeast and human type II topoisomerases. Enzyme-DNA and drug interactions, J. Biol. Chem. 274, 28246-28255.
56. Melek, M., Jones, J. M., O'Dea, M. H., Pais, G., Burke, T. R., Jr., Pommier, Y., Neamati, N., and Gellert, M. (2002) Effect of HIV integrase inhibitors on the RAG1/2 recombinase, Proc. Natl. Acad. Sci. U.S.A. 99, 134-137.
57. Mordasini, T., Curioni, A., and Andreoni, W. (2003) Why do divalent metal ions either promote or inhibit enzymatic reactions? The case of BamHI restriction endonuclease from combined quantum-classical simulations, J. Biol. Chem. 278, 4381-4384.
58. Kingma, P. S., and Osheroff, N. (1998) Topoisomerase II-mediated DNA cleavage and religation in the absence of base pairing: abasic lesions as a tool to dissect enzyme mechanism, J. Biol. Chem. 273, 17999-18002.
59. Liu, Q., and Wang, J. C. (1998) Identification of active site residues in the "GyrA" half of yeast DNA topoisomerase II, J. Biol. Chem. 273, 20252-20260.
60. Okada, Y., Ito, Y., Kikuchi, A., Nimura, Y., Yoshida, S., and Suzuki, M. (2000) Assignment of functional amino acids around the active site of human DNA topoisomerase IIα, J. Biol. Chem. 275, 24630-24638.
61. Andersen, A. H., Christiansen, K., Zechiedrich, E. L., Jensen, P. S., Osheroff, N., and Westergaard, O. (1989) Strand specificity of the topoisomerase II mediated double-stranded DNA cleavage reaction, Biochemistry 28, 6237-6244.
62. Lee, M. P., and Hsieh, T. (1992) Incomplete reversion of double stranded DNA cleavage mediated by Drosophila topoisomerase II: formation of single stranded DNA cleavage complex in the presence of an anti-tumor drug VM26, Nucleic Acids Res. 20, 5027-5033.
63. Berger, J. M., Fass, D., Wang, J. C., and Harrison, S. C. (1998) Structural similarities between topoisomerases that cleave one or both DNA strands, Proc. Natl. Acad. Sci. U.S.A. 95, 7876-7881.
64. Liu, Q., and Wang, J. C. (1999) Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases, Proc. Natl. Acad. Sci. U.S.A. 96, 881-886.
65. Corbett, A. H., Zechiedrich, E. L., and Osheroff, N. (1992) A role for the passage helix in the DNA cleavage reaction of eukaryotic topoisomerase II. A two-site model for enzyme-mediated DNA cleavage, J. Biol. Chem. 267, 683-686.
66. Kingma, P. S., and Osheroff, N. (1997) Apurinic sites are position-specific topoisomerase II-poisons, J. Biol. Chem. 272, 1148-1155.